BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$156M |
| 2 |
SPDR Gold Trust
GLD
|
+$142M |
| 3 |
Bank of America
BAC
|
+$107M |
| 4 |
iShares MSCI Brazil ETF
EWZ
|
+$92.9M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$81.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.53B |
| 2 |
Equinix
EQIX
|
+$2B |
| 3 |
Gilead Sciences
GILD
|
+$1.63B |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$1.48B |
| 5 |
United Therapeutics
UTHR
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.55% |
| 2 | Technology | 24.39% |
| 3 | Consumer Discretionary | 8.23% |
| 4 | Materials | 5.85% |
| 5 | Real Estate | 5.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPXL
2201
DELISTED
Impax Laboratories, Inc.
IPXL
| $22.3K | ﹤0.01% |
887
-17,767
| -95% | -$396K |
|
2202
Trex
TREX
$5.05B
| $21.9K | ﹤0.01% |
2,208
-35,976
| -94% | -$294K |
|
2203
Rithm Capital
RITM
$5.8B
| $21.9K | ﹤0.01% |
1,642
-33,219
| -95% | -$428K |
|
2204
Avista
AVA
$3.27B
| $21.9K | ﹤0.01% |
777
-15,586
| -95% | -$427K |
|
|
AEL
2205
DELISTED
American Equity Investment Life Holding Company
AEL
| $21.9K | ﹤0.01% |
830
-16,843
| -95% | -$384K |
|
2206
CACI
CACI
$14.7B
| $21.9K | ﹤0.01% |
299
-5,964
| -95% | -$423K |
|
2207
PUT
Capital One
COF
$139B
| $21.9K | ﹤0.01% |
7,960
| – | – |
|
2208
Home BancShares
HOMB
$6.3B
| $21.9K | ﹤0.01% |
1,172
-23,362
| -95% | -$402K |
|
|
VEDL
2209
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $21.8K | ﹤0.01% |
+1,656
| New | +$20.3K |
|
2210
Synaptics
SYNA
$4.24B
| $21.8K | ﹤0.01% |
420
-8,578
| -95% | -$420K |
|
2211
Acadia Healthcare
ACHC
$2.88B
| $21.7K | ﹤0.01% |
459
-9,298
| -95% | -$404K |
|
2212
Asbury Automotive
ABG
$3.77B
| $21.7K | ﹤0.01% |
404
-8,165
| -95% | -$421K |
|
|
TIVO
2213
DELISTED
TIVO INC
TIVO
| $21.6K | ﹤0.01% |
1,643
-33,303
| -95% | -$431K |
|
2214
CALL
Ralph Lauren
RL
$23.2B
| $21.5K | ﹤0.01% |
+320
| New | +$54.5K |
|
|
BLOX
2215
DELISTED
Infoblox Inc
BLOX
| $21.4K | ﹤0.01% |
649
-13,147
| -95% | -$515K |
|
|
ININ
2216
DELISTED
Interactive Intelligence Group, inc.
ININ
| $21.3K | ﹤0.01% |
316
-4,063
| -93% | -$260K |
|
2217
NorthWestern Energy
NWE
$4.4B
| $21.3K | ﹤0.01% |
491
-9,917
| -95% | -$443K |
|
2218
Neogen
NEOG
$2.56B
| $21.3K | ﹤0.01% |
1,240
-24,680
| -95% | -$429K |
|
2219
Nexstar Media Group
NXST
$5.82B
| $21.2K | ﹤0.01% |
380
-7,709
| -95% | -$368K |
|
|
CMA
2220
PUT
DELISTED
Comerica
CMA
| $21.1K | ﹤0.01% |
916
-330
| -26% | -$14.5K |
|
2221
La-Z-Boy
LZB
$1.66B
| $21K | ﹤0.01% |
679
-13,714
| -95% | -$355K |
|
|
VSI
2222
DELISTED
Vitamin Shoppe Inc.
VSI
| $21K | ﹤0.01% |
404
-7,921
| -95% | -$392K |
|
|
HI
2223
DELISTED
Hillenbrand
HI
| $21K | ﹤0.01% |
713
-14,396
| -95% | -$410K |
|
|
MGLN
2224
DELISTED
Magellan Health Services, Inc.
MGLN
| $21K | ﹤0.01% |
350
-7,002
| -95% | -$418K |
|
|
PACW
2225
DELISTED
PacWest Bancorp
PACW
| $20.9K | ﹤0.01% |
496
-10,062
| -95% | -$394K |
|
Similar funds
BNP Paribas Financial Markets's Q4 2013 Portfolio in Review
As of Q4 2013, BNP Paribas Financial Markets held 4,298 positions worth $137B, down 0.25% from $137B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
BNP Paribas Financial Markets withdrew a net $60.2B in Q4 2013, closing 193 positions and reducing 1,811 holdings. Its most notable exit was Innoviva, an estimated $182M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, BNP Paribas Financial Markets opened a new position in Ambev worth $22.5M.
- BNP Paribas Financial Markets's largest Q4 2013 buy was Ambev: 3,066,560 shares worth $22.5M.
- BNP Paribas Financial Markets added most to Apple in Q4 2013, an estimated $156M increase.
- BNP Paribas Financial Markets's biggest Q4 2013 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.53B.
- BNP Paribas Financial Markets fully exited Innoviva in Q4 2013, selling an estimated $182M.
- BNP Paribas Financial Markets's ten largest holdings make up 38% of its $137B portfolio in Q4 2013.
- BNP Paribas Financial Markets opened 1,712 new positions and closed 193 in Q4 2013.
- BNP Paribas Financial Markets's portfolio value fell 0.25% quarter-over-quarter to $137B.
Based on BNP Paribas Financial Markets's 13F filing for Q4 2013, filed 12 Feb 2014.